Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid supplementation in adults with short bowel syndrome
2006-001406-83Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ursodeoxycholic acid in short bowel syndrome (SBS), sponsored by Hospices Civils de Lyon. Primary endpoints: Cholesterol metabolism and Triglyceride metabolism. Started Mar 2007; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2006-001406-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001406-83.